Blue Trust Inc. grew its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 139.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,026 shares of the company's stock after purchasing an a
